Heartflow (HTFL) stock broke out Friday, helped by an "outsized" guidance raise and second-quarter beat. The San Francisco-based company uses artificial intelligence and advanced computer models to help diagnose and manage coronary artery disease. It methods don't require invasive surgery.
During the second quarter, Heartflow notched $64.1 million in sales, growing 48% year over year and beating expectations for $56.6…
Extract — continue reading at the source.
Related stories
Orion Properties (ONL) Q2 2026 Earnings Call Transcript
SpaceX Stock Drops as Musk’s Rockets Face a Fresh Rival
Rocket Companies (RKT) Q2 2026 Earnings Call Transcript
US consumers sour on economy as inflation concerns remain in focus, UMich survey says
How England’s brutal summer heat is affecting farm animals and crops
Walmart set for in-line Q2 as investors eye tariff refund plans, 2H guidance